Microneedle drug delivery system based on hyaluronic acid for improving therapeutic efficiency of hypertrophic scars
Authors:
- 11 January 2025
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 297, 139790
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Xiamen Municipality (3502Z20227074)
- National Natural Science Foundation of China (3502Z20227074)
- Natural Science Foundation of Fujian Province (2022J05320)
- Natural Science Foundation of Fujian Province (2022J011405)
This publication has 34 references indexed in Scilit:
- CLC-3 regulates TGF-β/smad signaling pathway to inhibit the process of fibrosis in hypertrophic scarHeliyon, 2024
- Microneedle patch loaded with ferritin-nanocaged doxorubicin for locally targeted drug delivery and efficient skin cancer treatmentParticuology, 2023
- A review of pharmacokinetic and pharmacological properties of asiaticoside, a major active constituent of Centella asiatica (L.) Urb.Journal of Ethnopharmacology, 2022
- pH-responsive hyaluronic acid nanoparticles codelivering DOX and ICG for effectively chemo-photothermal combination therapyJournal of Nanoparticle Research, 2021
- Fabrication, evaluation and applications of dissolving microneedlesInternational Journal of Pharmaceutics, 2021
- Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formationBiomedicine & Pharmacotherapy, 2020
- Polymeric microneedles for controlled transdermal drug deliveryJournal of Controlled Release, 2019
- Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjectsBiomaterials, 2017
- The molecular mechanism of hypertrophic scarJournal of Cell Communication and Signaling, 2013
- Nonsurgical therapy for postoperative hypertrophic scarsEuropean Surgery, 2012